FAM20C Modulates Neuronal Differentiation in Hypoxic–Ischemic Brain Damage via KAP1 Phosphorylation and LINE1 RNA m6A ‐Dependent H3K9me3 Regulation
Cell Proliferation · 2026
DOI: 10.1111/cpr.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Chen-Xi Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Cell Differentiation, Neurons, Tripartite Motif-Containing Protein 28. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Suzhou Science and Technology Development Plan, National Natural Science Foundation of China, Suzhou Science and Technology Development Plan.
Abstract (Originalsprache)
Neurodevelopmental impairment due to hypoxic–ischemic brain damage (HIBD) lacks effective biomarkers and therapeutic targets. Based on some cues from published papers, extracellular serine/threonine protein kinase FAM20C was speculated to play a crucial role in the neurodevelopmental impairment of HIBD. In this study, FAM20C was found suppressed in the ischemic hippocampal tissue of HIBD. The inhibition of FAM20C caused by HIBD affected cell differentiation and subsequently caused cognitive impairment. KAP1 was identified as a kinase substrate of FAM20C in the central nervous system. The regulation of the YTHDC1‐NCL‐KAP1‐LINE1 RNA complex by FAM20C was mediated through KAP1 phosphorylation and LINE1 RNA m6A. These alterations consequently modulated the establishment of the H3K9me3 modification on LINE1 DNA, thereby resulting in neuronal differentiation. Furthermore, E2F4, identified as a transcription factor, regulated FAM20C in HIBD. This research has clarified the novel association between FAM20C and HIBD, laying the foundation for innovative diagnostic and therapeutic strategies to counteract neurodevelopmental disruptions arising from neonatal hypoxic–ischemic encephalopathy (HIE).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, China.
- Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, China.
- Department of Neonatology, Children's Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Chen-Xi Feng
Förderung
- Project of Suzhou Science and Technology Development Plan
- National Natural Science Foundation of China
- Suzhou Science and Technology Development Plan
- GUSU Health Talent Research Project
- Key Technology Research and Jiangsu Medical Association Pediatric Medicine Special Fund Project
Zitieren
APA
Feng, C. X., Wang, M., Li, G., Chu, S. J., Wu, D., Hu, X. H., Xu, L. X., Li, M., & Feng, X. (2026). FAM20C Modulates Neuronal Differentiation in Hypoxic–Ischemic Brain Damage via KAP1 Phosphorylation and LINE1 RNA m6A ‐Dependent H3K9me3 Regulation. Cell Proliferation. https://doi.org/10.1111/cpr.70073
Vancouver
Feng CX, Wang M, Li G, Chu SJ, Wu D, Hu XH, et al. FAM20C Modulates Neuronal Differentiation in Hypoxic–Ischemic Brain Damage via KAP1 Phosphorylation and LINE1 RNA m6A ‐Dependent H3K9me3 Regulation. Cell Proliferation. 2026. doi:10.1111/cpr.70073
BibTeX
@article{Feng2026,
author = {Feng, Chen-Xi and Wang, Mei and Li, Gen and Chu, Si-Jia and Wu, Di and Hu, Xiao-Han and Xu, Li-Xiao and Li, Mei and Feng, Xing},
title = {FAM20C Modulates Neuronal Differentiation in Hypoxic–Ischemic Brain Damage via KAP1 Phosphorylation and LINE1 RNA m6A ‐Dependent H3K9me3 Regulation},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70073}
}
EUVIMED